J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...

CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors ...

Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral ...

Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ...

Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract ...

From cardiac ablation devices to OTC glucose sensors, explore how breakthrough medical technologies are disrupting ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, ...

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...

At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use ...